» Articles » PMID: 30235311

Performance of the New Clinical Case Definitions of Pertussis in Pertussis Suspected Infection and Other Diagnoses Similar to Pertussis

Overview
Journal PLoS One
Date 2018 Sep 21
PMID 30235311
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In an effort to improve the pertussis diagnosis, the Global Pertussis Initiative (GPI) proposed an algorithm of the signs/symptoms of pertussis for three age groups: 0-3 months, 4 months to 9 years, and ≥10 years of age.

Methods: We evaluated the accuracy of the clinical case definitions for pertussis proposed by the GPI using laboratory-confirmed pertussis as a reference standard for four groups: clinically suspected pertussis without comorbidity; asthma exacerbation; allergic constitution, and other diagnoses (bronchitis, bronchiolitis, laryngitis, and tracheitis). We included only patients who fulfilled one or more criteria of clinical case definitions for the age groups (0-3 months, 4 months-9 years, and ≥10 years of age). The data for this prospective epidemiological study were collected between 1st January 2013-31st December 2016 at the outpatients and inpatients health care settings in the South Bačka District of Autonomous Province of Vojvodina, Serbia. We evaluated accuracy of the certain sign and symptom combinations of GPI case definitions based on their sensitivity, specificity, and likelihood ratios.

Results: A total of 1043 participants were included, with 306 (29.3%) laboratory-confirmed pertussis cases. In patients aged 0-3 months, whoop and apnoea associated with laboratory confirmation of pertussis. In patients aged 4 months-9 years with a pertussis suspicion infection or with one of the other diagnoses, the highest accuracy was found for whoop combined with apnoea or post-tussive emesis. In patients aged 10 years and older, several different sign and symptom combinations were associated with an increased risk of pertussis among all enrolment diagnoses. There were fewer hospitalizations among the fully vaccinated children than in partly or unvaccinated children aged 4 months to 6 years (20.7% vs. 60.0%, p = 0.017).

Conclusions: The numerous sign and symptom combinations in the observed case definitions were good predictors for laboratory-confirmed pertussis among all enrolment diagnoses, therefore suggesting the necessity for increased awareness of possibility for pertussis in patients with certain pertussis-like medical conditions.

Citing Articles

Development and validation of a diagnostic prediction model for children with pertussis.

Gao Q, Xu D, Guan X, Jia P, Lei X Sci Rep. 2024; 14(1):17154.

PMID: 39060316 PMC: 11282082. DOI: 10.1038/s41598-024-65856-x.


Pertussis Epidemiology in the Autonomous Province of Vojvodina, Serbia, 1948-2023.

Ristic M, Medic S, Vukovic V, Rajcevic S, Koprivica M, Banjac J Vaccines (Basel). 2024; 12(5).

PMID: 38793776 PMC: 11126017. DOI: 10.3390/vaccines12050525.


Risk Factors of Pertussis Among Older Adults in South Korea: A Nationwide Health Data-Based Case-Control Study.

Kim H, Shin J, Chen J, Kim J, Noh Y, Cheong H Infect Dis Ther. 2023; 12(2):545-561.

PMID: 36588139 PMC: 9925654. DOI: 10.1007/s40121-022-00747-0.


A data driven clinical algorithm for differential diagnosis of pertussis and other respiratory infections in infants.

Tozzi A, Gesualdo F, Rizzo C, Carloni E, Russo L, Campagna I PLoS One. 2020; 15(7):e0236041.

PMID: 32702054 PMC: 7377414. DOI: 10.1371/journal.pone.0236041.


Diagnostic limitations of clinical case definitions of pertussis in infants and children with severe lower respiratory tract infection.

Muloiwa R, Nicol M, Hussey G, Zar H PLoS One. 2020; 15(7):e0235703.

PMID: 32678857 PMC: 7367487. DOI: 10.1371/journal.pone.0235703.

References
1.
Crespo I, Toledo D, Soldevila N, Jordan I, Solano R, Castilla J . Characteristics of Hospitalized Cases of Pertussis in Catalonia and Navarra, Two Regions in the North of Spain. PLoS One. 2015; 10(10):e0139993. PMC: 4595087. DOI: 10.1371/journal.pone.0139993. View

2.
Braman S . Postinfectious cough: ACCP evidence-based clinical practice guidelines. Chest. 2006; 129(1 Suppl):138S-146S. DOI: 10.1378/chest.129.1_suppl.138S. View

3.
Gustafsson L, Hessel L, Storsaeter J, Olin P . Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age. Pediatrics. 2006; 118(3):978-84. DOI: 10.1542/peds.2005-2746. View

4.
Cherry J, Tan T, von Konig C, Forsyth K, Thisyakorn U, Greenberg D . Clinical definitions of pertussis: Summary of a Global Pertussis Initiative roundtable meeting, February 2011. Clin Infect Dis. 2012; 54(12):1756-64. PMC: 3357482. DOI: 10.1093/cid/cis302. View

5.
Klein N, Bartlett J, Rowhani-Rahbar A, Fireman B, Baxter R . Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med. 2012; 367(11):1012-9. DOI: 10.1056/NEJMoa1200850. View